Ivory A Phase Iii Open Label, Randomized, 2 Arm Study of Ixabepilone Administered Every 21 Days Versus Paclitaxel Or Doxorubicin Administered Every 21 Days In Women with Advanced Endometrial Cancer Who Have Previously Been Treated with Chemotherapy Trademark Details
Word Mark | Ivory a Phase III Open Label, Randomized, 2 Arm Study of Ixabepilone Administered Every 21 Days Versus Paclitaxel or Doxorubicin Administered Every 21 Days in Women with Advanced Endometrial Cancer Who Have Previously Been Treated with Chemotherapy |
---|---|
Status | Dead 622 — Misassigned Serial Number |
Current Owner
Serial Number | 77762649 |
---|---|
Status Date | Wednesday, June 24, 2009 |
Filing Date | Wednesday, June 24, 2009 |
Attorney | Tanya Fickenscher Leonard |
Correspondent
NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
TRADEMARK DEPARTMENT
NEW YORK, NY 10154
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
TRADEMARK DEPARTMENT
NEW YORK, NY 10154
Case File Statements
Goods & Services | Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use |
---|
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Monday, June 22, 2009 |
Primary Code | 042 |
Trademark Timeline
-
Jun 22 2009New Application Entered In Tram
-
Dec 17 2009Attorney Revoked And/or Appointed
-
Dec 17 2009Teas Revoke/appoint Attorney Received